Name | kt 5823 |
---|---|
Synonyms |
MFCD00132119
(9S,10R,12R)-2,3,9,10,11,12-hexahydro-10-methoxy-2,9-dimethyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-l][1,6]benzodiazocine-10-carboxylic acid methyl ester |
Description | KT5823, a selective the cGMP-dependent protein kinase (PKG) inhibitor with an Ki value of 0.23 μM, it also inhibits PKA and PKC with Ki values of 10 μM and 4 μM, respectively[1]. KT5823 is a staurosporine-related protein kinase inhibitor, increases thyroid-stimulating hormone-induced (Na+/I- symporter) NIS expression, and iodide uptake in thyroid cells[2]. KT5823 arrests cells after the G0/G1 boundary and causes increases in the levels of apoptotic DNA fragmentation[3]. |
---|---|
Related Catalog | |
Target |
PKA:10 μM (Ki) PKC:4 μM (Ki) |
References |
Density | 1.52g/cm3 |
---|---|
Boiling Point | 629.2ºC at 760mmHg |
Molecular Formula | C29H25N3O5 |
Molecular Weight | 495.52600 |
Flash Point | 334.3ºC |
Exact Mass | 495.17900 |
PSA | 74.93000 |
LogP | 4.58930 |
Vapour Pressure | 9.67E-16mmHg at 25°C |
Index of Refraction | 1.763 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Hazard Codes | Xi |
RIDADR | NONH for all modes of transport |
~% 126643-37-6 |
Literature: Organic Process Research and Development, , vol. 3, # 2 p. 131 - 134 |
Precursor 1 | |
---|---|
DownStream 0 |